FCGR2C Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-09539
Key Product Details
Species Reactivity
Human
Applications
Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit
Concentration
0.5 mg/ml
Product Specifications
Immunogen
The immunogen is a synthetic peptide directed towards the N-terminal region of Human FCGR2C (NP_963857). Peptide sequence GTHSPESDSIPWFHNGNLIPTHTQPSYRFKANNNDSGEYTCQTGQTSLSD
Clonality
Polyclonal
Host
Rabbit
Theoretical MW
35 kDa.
Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.
Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.
Scientific Data Images for FCGR2C Antibody
Western Blot: FCGR2C Antibody [NBP3-09539]
Western Blot: FCGR2C Antibody [NBP3-09539] - Western blot analysis of FCGR2C in Hela Whole cell lysates. Antibody dilution at 1.0ug/mlApplications for FCGR2C Antibody
Application
Recommended Usage
Western Blot
1.0 ug/ml
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS, 2% Sucrose
Preservative
0.09% Sodium Azide
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: Fc gamma RIIC/CD32c
Long Name
Fc gamma Receptor II
Alternate Names
CD32c, FCGR2C, FcgRIIC, FCRIIC
Gene Symbol
FCGR2C
Additional Fc gamma RIIC/CD32c Products
Product Specific Notices for FCGR2C Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...